Year	Event
Mar 2016	Surgical intervention: unilateral carpal tunnel syndrome.
Nov 2019	Diagnosis of wild-type transthyretin amyloidosis (ATTRwt) (screening study) (scintigraphy and endomyocardial biopsy positive for ATTRwt).
Day 0 Aug 2022	Current presentation: shortness of breath, palpitation (atrial fibrillation), and mild swelling of lower legs. Treatment with diuretics, beta-blocker, anti-coagulation, and planned sub-acute direct cardioversion. Discharged for outpatient care.
Day 7	Result of 48-h Holter monitoring: paroxysmal atrial fibrillation (2 h). Three episodes of ventricular tachycardia (VT), ∼20% ventricular ectopic beats.
Day 8	Coronary angiography: proximal left anterior descending artery stenosis—percutaneous coronary intervention performed simultaneously. Anti-thrombotic and anti-cholesterol treatment added.
Day 13	Implantation of a dual chamber implantable cardioverter defibrillator (DDD-ICD).
Day 42 Sep 2022	At 1 month follow-up: New York Heart Association (NYHA) 1, no VT, and reduction of ventricular ectopy.
Day 104 Nov 2022	Three-month DDD-ICD monitoring: no evidence of VT.